We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Micro-scaled Method Holds Promise for Cancer Diagnosis

News   Jan 28, 2020 | Original story from the Baylor College of Medicine

 
Micro-scaled Method Holds Promise for Cancer Diagnosis

The image shows cell culture of human breast cancer conditionally reprogrammed cells. Fluorescence red color represents MHC-I, and nuclei are shown in blue. Credit: National Cancer Institute \ Georgetown Lombardi Comprehensive Cancer Center (Creator: Ewa Krawczyk)

 
 
 

RELATED ARTICLES

CT Provides Best Diagnosis for Coronavirus

News

In a study of more than 1,000 patients, chest CT outperformed lab testing in the diagnosis of 2019 novel coronavirus disease (COVID-19).

READ MORE

Link Between Gene and Exercise Capacity

News

In a study published in The New England Journal of Medicine, a research team has found a link between a genetic mutation that affects cellular oxygen sensing and a patient’s limited exercise capacity.

READ MORE

Research Outlines How Drug in Clinical Trial for Coronavirus Works

News

A new study published in the Journal of Biological Chemistry outlines how an antiviral drug that is currently being tested in patients with the novel coronavirus (COVID-19), remdesivir, works.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE